Literature DB >> 21951179

Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex.

Israt Z Shahid1, Ahmed A Rahman, Paul M Pilowsky.   

Abstract

BACKGROUND AND
PURPOSE: The rostral ventrolateral medulla (RVLM) maintains sympathetic nerve activity (SNA), and integrates adaptive reflexes. Orexin A-immunoreactive neurones in the lateral hypothalamus project to the RVLM. Microinjection of orexin A into RVLM increases blood pressure and heart rate. However, the expression of orexin receptors, and effects of orexin A in the RVLM on splanchnic SNA (sSNA), respiration and adaptive reflexes are unknown. EXPERIMENTAL APPROACH: The effect of orexin A on baseline cardio-respiratory variables as well as the somato-sympathetic, baroreceptor and chemoreceptor reflexes in RVLM were investigated in urethane-anaesthetized, vagotomized and artificially ventilated male Sprague-Dawley rats (n= 50). orexin A and its receptors were detected with fluorescence immunohistochemistry. KEY
RESULTS: Tyrosine hydroxylase-immunoreactive neurones in the RVLM were frequently co-localized with orexin 1 (OX(1) ) and orexin 2 (OX(2) ) receptors and closely apposed to orexin A-immunoreactive terminals. Orexin A injected into the RVLM was pressor and sympatho-excitatory. Peak effects were observed at 50 pmol with increased mean arterial pressure (42 mmHg) and SNA (45%). Responses to orexin A (50 pmol) were attenuated by the OX(1) receptor antagonist, SB334867, and reproduced by the OX(2) receptor agonist, [Ala(11) , D-Leu(15) ]orexin B. Orexin A attenuated the somato-sympathetic reflex but increased baroreflex sensitivity. Orexin A increased or reduced sympatho-excitation following hypoxia or hypercapnia respectively. CONCLUSIONS AND IMPLICATIONS: Although central cardio-respiratory control mechanisms at rest do not rely on orexin, responses to adaptive stimuli are dramatically affected by the functional state of orexin receptors.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21951179      PMCID: PMC3413863          DOI: 10.1111/j.1476-5381.2011.01694.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

1.  Vasostatin I (CgA17-76) vasoconstricts rat splanchnic vascular bed but does not affect central cardiovascular function.

Authors:  Ahmed A Rahman; Israt Z Shahid; Angelina Y Fong; Andrew M Hammond; Paul M Pilowsky
Journal:  Auton Neurosci       Date:  2011-09-19       Impact factor: 3.145

2.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem.

Authors:  D Sunter; I Morgan; C M Edwards; C L Dakin; K G Murphy; J Gardiner; S Taheri; E Rayes; S R Bloom
Journal:  Brain Res       Date:  2001-07-13       Impact factor: 3.252

4.  Intrathecal kynurenate but not benextramine blocks hypoxic sympathoexcitation in chemodenervated anesthetized rats.

Authors:  M K Sun; D J Reis
Journal:  J Auton Nerv Syst       Date:  1994-04

5.  Cardiovascular neurons of brain stem with projections to spinal cord.

Authors:  D L Brown; P G Guyenet
Journal:  Am J Physiol       Date:  1984-12

6.  Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat.

Authors:  Thomas E Dick; Yee-Hsee Hsieh; Ning Wang; Nanduri Prabhakar
Journal:  Exp Physiol       Date:  2006-11-30       Impact factor: 2.969

7.  Properties of presympathetic neurones in the rostral ventrolateral medulla in the rat: an intracellular study "in vivo'.

Authors:  J Lipski; R Kanjhan; B Kruszewska; W Rong
Journal:  J Physiol       Date:  1996-02-01       Impact factor: 5.182

8.  Galanin microinjection into rostral ventrolateral medulla of the rat is hypotensive and attenuates sympathetic chemoreflex.

Authors:  Stephen B G Abbott; Paul M Pilowsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

9.  Somatostatin 2A receptor-expressing presympathetic neurons in the rostral ventrolateral medulla maintain blood pressure.

Authors:  Peter G R Burke; Qun Li; Monique L Costin; Simon McMullan; Paul M Pilowsky; Ann K Goodchild
Journal:  Hypertension       Date:  2008-11-10       Impact factor: 10.190

10.  Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  J Neurophysiol       Date:  2002-05       Impact factor: 2.714

View more
  29 in total

Review 1.  Major Autonomic Neuroregulatory Pathways Underlying Short- and Long-Term Control of Cardiovascular Function.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Upregulation of orexin receptor in paraventricular nucleus promotes sympathetic outflow in obese Zucker rats.

Authors:  Jing-Jing Zhou; Fang Yuan; Yi Zhang; De-Pei Li
Journal:  Neuropharmacology       Date:  2015-08-12       Impact factor: 5.250

3.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

Review 4.  Functional Changes of Orexinergic Reaction to Psychoactive Substances.

Authors:  Vincenzo Monda; Monica Salerno; Francesco Sessa; Renato Bernardini; Anna Valenzano; Gabriella Marsala; Christian Zammit; Roberto Avola; Marco Carotenuto; Giovanni Messina; Antonietta Messina
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

5.  Differences in carbachol dose, pain condition, and sex following lateral hypothalamic stimulation.

Authors:  J E Holden; E Wang; J R Moes; M Wagner; A Maduko; Y Jeong
Journal:  Neuroscience       Date:  2014-04-20       Impact factor: 3.590

Review 6.  Implicating the potential role of orexin in hypertension.

Authors:  Monika Rani; Raghuvansh Kumar; Pawan Krishan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-16       Impact factor: 3.000

7.  Hypocretin Deficiency Associated with Narcolepsy Type 1 and Central Hypoventilation Syndrome in Neurosarcoidosis of the Hypothalamus.

Authors:  Mary Catherine Mayo; Jane C Deng; Jeffrey Albores; Michelle Zeidler; Ronald M Harper; Alon Y Avidan
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

8.  Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension.

Authors:  Michael J Huber; Yuanyuan Fan; Enshe Jiang; Fengli Zhu; Robert A Larson; Jianqun Yan; Ningjun Li; Qing-Hui Chen; Zhiying Shan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-30       Impact factor: 4.733

Review 9.  The Orexin System and Hypertension.

Authors:  Michael J Huber; Qing-Hui Chen; Zhiying Shan
Journal:  Cell Mol Neurobiol       Date:  2017-03-27       Impact factor: 5.046

10.  Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats.

Authors:  Aihua Li; Charles C T Hindmarch; Eugene E Nattie; Julian F R Paton
Journal:  J Physiol       Date:  2013-05-13       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.